{
    "id": "0056",
    "question": "An otherwise healthy 26-year-old man comes to the physician for medication counseling after recently being diagnosed with schizophrenia. Risperidone therapy is initiated. This patient is at increased risk for which of the following adverse effects?",
    "options": {
        "A": "Agranulocytosis",
        "B": "Shortened QT interval",
        "C": "Gynecomastia",
        "D": "Weight loss"
    },
    "answer": "C",
    "predict": "Here's the step-by-step thinking for the question: The patient is a 26-year-old man who has been diagnosed with schizophrenia and is starting risperidone therapy. To answer this question, we need to consider the side effect profile of risperidone. Risperidone is a second-generation (atypical) antipsychotic medication that is known for its efficacy in treating schizophrenia. However, like all antipsychotics, it has potential side effects. Option A, agranulocytosis, is a rare but potentially life-threatening side effect associated with clozapine, another second-generation antipsychotic. While clozapine is a related agent, risperidone is not typically associated with agranulocytosis. Option B, shortened QT interval, is a potential side effect of some medications, but it is not a commonly reported side effect of risperidone. Option C, gynecomastia, is a potential side effect of some antipsychotics, particularly those with strong estrogenic or anti-androgenic effects. Risperidone can cause gynecomastia, but it is not the most common side effect. Option D, weight loss, is not a typical side effect of risperidone. In fact, many atypical antipsychotics, including risperidone, are known to cause weight gain rather than weight loss. Considering the options, the most likely side effect of risperidone is gynecomastia, which is a well-documented potential side effect of this medication. Here is the output in JSON format: {\"step_by_step_thinking\": \"The patient is taking risperidone for schizophrenia, and we need to consider the potential side effects of this medication. Risperidone is a second-generation antipsychotic known for its efficacy in treating schizophrenia. While it has several potential side effects, agranulocytosis is not typically associated with risperidone. Shortened QT interval is also not a commonly reported side effect. Weight loss is not a typical side effect of risperidone, as many atypical antipsychotics, including risperidone, are known to cause weight gain. Therefore, the most likely side effect of risperidone is gynecomastia, which is a well-documented potential side effect of this medication. \", \"answer_choice\": \"C\"}",
    "snippets": [
        {
            "id": "Neurology_Adams_12321",
            "title": "Neurology_Adams",
            "content": "develop leukopenia, which may prove fatal; there is less risk with the related agent, olanzapine, but leukopenia and agranulocytosis have been reported in rare instances with it as well. Orthostatic hypotension, tachycardia, fever, and hypersalivation may be troublesome in the first days and weeks of therapy with any agent in this class. Risperidone is a potent serotonin and dopamine receptor antagonist. Low doses reportedly attenuate the negative symptoms of schizophrenia (apathy, emotional withdrawal, lack of social interaction) and the incidence of extrapyramidal side effects is low provided that the dosage is kept below 6 mg daily."
        },
        {
            "id": "Pharmacology_Katzung_3100",
            "title": "Pharmacology_Katzung",
            "content": "Charles DeBattista, MD * severe akathisia. Although more costly, lurasidone is then prescribed, which, over the course of several weeks of treatment, improves his symptoms and is tolerated by the patient. What signs and symptoms would support an initial diagnosis of schizophrenia? In the treatment of schizophre-nia, what benefits do the second-generation antipsychotic drugs offer over the traditional agents such as haloperidol? In addition to the management of schizophrenia, what other clinical indications warrant consideration of the use of drugs nominally classified as antipsychotics? A 19-year-old male student is brought into the clinic by his mother who has been concerned about her son\u2019s erratic behavior and strange beliefs. He destroyed a TV because he felt the TV was sending harassing messages to him. In addition, he reports hearing voices telling him that fam-ily members are trying to poison his food. As a result, he is not eating. After a diagnosis is made, haloperidol is"
        },
        {
            "id": "InternalMed_Harrison_31760",
            "title": "InternalMed_Harrison",
            "content": "rise in prolactin level. Approximately 30% of patients who do not benefit from conventional antipsychotic agents will have a better response to this drug, which also has a demonstrated superiority to other antipsychotic agents in preventing suicide; however, its side effect profile makes it most appropriate for treatment-resistant cases. Risperidone, a benzisoxazole derivative, is more potent at 5-HT2 than D2 receptor sites, like clozapine, but it also exerts significant \u03b12 antagonism, a property that may contribute to its perceived ability to improve mood and increase motor activity. Risperidone is not as effective as clozapine in treatment-resistant cases but does not carry a risk of blood dyscrasias. Olanzapine is similar neurochemically to clozapine but has a significant risk of inducing weight gain. Quetiapine is distinct in having a weak D2 effect but potent \u03b11 and histamine blockade. Ziprasidone causes minimal weight gain and is unlikely to increase prolactin but may increase"
        },
        {
            "id": "First_Aid_Step2_1260",
            "title": "First_Aid_Step2",
            "content": "Life-threatening muscle rigidity, fever, and rhabdomyolysis. Amenorrhea, bradycardia, and abnormal body image in a young female. SSRIs. MAOIs. Patient on dopamine antagonist. Conversion disorder. Neuroleptic malignant syndrome. Anorexia. A 35-year-old man has recurrent episodes of palpitations, diaphoresis, and fear of going crazy. The most serious side effect of clozapine. A 21-year-old man has three months of social withdrawal, worsening grades, \ufb02attened affect, and concrete thinking. Key side effects of atypical antipsychotics. A young weight lifter receives IV haloperidol and complains that his eyes are deviated sideways. Diagnosis? Treatment? Medication to avoid in patients with a history of alcohol withdrawal seizures. A 13-year-old boy has a history of theft, vandalism, and violence toward family pets. A five-month-old girl has \u2193 head growth, truncal dyscoordination, and \u2193 social interaction."
        },
        {
            "id": "InternalMed_Harrison_31762",
            "title": "InternalMed_Harrison",
            "content": "Antipsychotic agents are effective in 70% of patients presenting with a first episode. Improvement may be observed within hours or days, but full remission usually requires 6\u20138 weeks. The choice of agent depends principally on the side effect profile and cost of treatment or on a past personal or family history of a favorable response to the drug in question. Atypical agents appear to be more effective in treating negative symptoms and improving cognitive function. An equivalent treatment response can usually be achieved with relatively low doses of any drug selected (i.e., 4\u20136 mg/d of haloperidol, 10\u201315 mg of olanzapine, or 4\u20136 mg/d of risperidone). Doses in this range result in >80% D2 receptor blockade, and there is little evidence that higher doses increase either the rapidity or degree of response. Maintenance treatment requires careful attention to the possibility of relapse and monitoring for the development of a movement disorder. Intermittent drug treatment is less effective"
        },
        {
            "id": "Neurology_Adams_9677",
            "title": "Neurology_Adams",
            "content": "derivative, risperidone. Molindone and loxapine are about as effective as the phenothiazines in the management of schizophrenia and their side effects are similar, although claims have been made that they are less likely to induce tardive dyskinesias and seizures. Their main use is in patients who are not responsive to the older drugs or who suffer intolerable side effects from them."
        },
        {
            "id": "InternalMed_Harrison_30442",
            "title": "InternalMed_Harrison",
            "content": "Patients with mild disease often only require education and counseling (for themselves and family members). Drug treatment is indicated when the tics are disabling and interfere with quality of life. Therapy is individualized, and there is no singular treatment regimen that has been properly evaluated in double-blind trials. Some physicians use the \u03b1-agonist clonidine, starting at low doses and gradually increasing the dose and frequency until satisfactory control is achieved. Guanfacine (0.5\u20132 mg/d) is an \u03b1-agonist that is preferred by some because it only requires once-a-day dosing. Other physicians prefer to use neuroleptics. Atypical neuroleptics are usually used initially (risperidone, olanzapine, ziprasidone) because they are thought to be associated with a reduced risk of tar-dive dyskinesia. If they are not effective, low doses of classical neuroleptics such as haloperidol, fluphenazine, pimozide, or tiapride can be tried because the risk of tardive dyskinesia in young people"
        },
        {
            "id": "InternalMed_Harrison_31763",
            "title": "InternalMed_Harrison",
            "content": "of response. Maintenance treatment requires careful attention to the possibility of relapse and monitoring for the development of a movement disorder. Intermittent drug treatment is less effective than regular dosing, but gradual dose reduction is likely to improve social functioning in many schizophrenic patients who have been maintained at high doses. If medications are completely discontinued, however, the relapse rate is 60% within 6 months. Long-acting injectable preparations (risperidone, paliperidone, olanzapine, aripiprazole) are considered when noncompliance with oral therapy leads to relapses but should not be considered interchangeable, because the agents differ in their indications, injection intervals and sites/volumes, and possible adverse reactions, among other factors. In treatment-resistant patients, a transition to clozapine usually results in rapid improvement, but a prolonged delay in response in some cases necessitates a 6to 9-month trial for maximal benefit to"
        },
        {
            "id": "InternalMed_Harrison_31769",
            "title": "InternalMed_Harrison",
            "content": "The CATIE study, a large-scale investigation of the effectiveness of antipsychotic agents in \u201creal-world\u201d patients, revealed a high rate of discontinuation of treatment over 18 months. Olanzapine showed greater effectiveness than quetiapine, risperidone, perphenazine, or ziprasidone but also a higher discontinuation rate due to weight gain and metabolic effects. Surprisingly, perphenazine, a first-generation agent, showed little evidence of inferiority to newer drugs. Drug treatment of schizophrenia is by itself insufficient. Educational efforts directed toward families and relevant community resources have proved to be necessary to maintain stability and optimize outcome. A treatment model involving a multidisciplinary case-management team that seeks out and closely follows the patient in the community has proved particularly effective."
        },
        {
            "id": "Pharmacology_Katzung_3160",
            "title": "Pharmacology_Katzung",
            "content": "The best guide for selecting a drug for an individual patient is the patient history of past responses to drugs. At present, clozapine is limited to those patients who have failed to respond to substantial doses of conventional antipsychotic drugs. The agranulocytosis and seizures associated with this drug prevent more widespread use. Risperidone\u2019s improved adverse-effect profile (compared with that of haloperidol) at dosages of 6 mg/d or less and the apparently lower risk of tardive dyskinesia have contributed to its widespread use. Olanzapine and quetiapine may have even lower risks and have also achieved widespread use. At this writing, aripiprazole is the most commonly prescribed second-generation antipsychotic in the USA due to a relatively favorable side effect profile and aggressive marketing."
        },
        {
            "id": "First_Aid_Step2_1262",
            "title": "First_Aid_Step2",
            "content": "A schizophrenic patient takes haloperidol for one year and develops uncontrollable tongue movements. Diagnosis? Treatment? A man unexpectedly \ufb02ies across the country, takes a new name, and has no memory of his prior life. Panic disorder. Agranulocytosis. Schizophreniform disorder (diagnosis of schizophrenia requires \u2265 6 months of symptoms). Weight gain, type 2 DM, QT prolongation. Acute dystonia (oculogyric crisis). Treat with benztropine or diphenhydramine. Neuroleptics. Conduct disorder. Rett\u2019s disorder. Acute mania. Start a mood stabilizer (e.g., lithium). Malingering. Factitious disorder (Munchausen syndrome). Substance abuse. Phencyclidine hydrochloride (PCP) intoxication. Depersonalization disorder. Frotteurism (a paraphilia). Tardive dyskinesia. \u2193 or discontinue haloperidol and consider another antipsychotic (e.g., risperidone, clozapine). Dissociative fugue. Risk factors for DVT. Criteria for exudative effusion. Causes of exudative effusion."
        },
        {
            "id": "Neurology_Adams_12320",
            "title": "Neurology_Adams",
            "content": "choice. The addition of a second drug, specifically combining clozapine with risperidone, was not found to be useful in the trial conducted by Honer and colleagues. Moreover, in another one of the effectiveness trials sponsored by the National Institutes of Mental Health, Lieberman and colleagues (\u201cCATIE\u201d Investigators) found that the majority of chronic schizophrenics discontinued their antipsychosis drugs within 18 months. Among the medications they compared, olanzapine was slightly more effective than quetiapine, risperidone, and ziprasidone; of equal interest, the phenothiazine perphenazine was equivalent in efficacy and tolerability to the last 3 second-generation (atypical) drugs. Approximately 1 percent of patients treated with one of the most effective drugs, clozapine, develop leukopenia, which may prove fatal; there is less risk with the related agent, olanzapine, but leukopenia and agranulocytosis have been reported in rare instances with it as well. Orthostatic"
        },
        {
            "id": "InternalMed_Harrison_30231",
            "title": "InternalMed_Harrison",
            "content": "of atypical antipsychotics, such as risperidone, quetiapine, and olanzapine, are being used in low doses to treat these neuropsychiatric symptoms. The few controlled studies comparing drugs against behavioral intervention in the treatment of agitation suggest mild efficacy with significant side effects related to sleep, gait, and cardiovascular complications, including an increased risk of death. All antipsychotics carry a black box FDA warning and should be used with caution in the demented elderly; however, careful, daily, nonpharmacologic behavior management is often not available, rendering medications necessary for some patients. Finally, medications with strong anticholinergic effects should be vigilantly avoided, including prescription and over-the-counter sleep aids (e.g., diphenhydramine) or incontinence therapies (e.g., oxybutynin)."
        },
        {
            "id": "Pharmacology_Katzung_3156",
            "title": "Pharmacology_Katzung",
            "content": "Some of the second-generation antipsychotic drugs produce more weight gain and increases in lipids than some first-generation drugs. A small percentage of patients develop diabetes mellitus, most often seen with clozapine and olanzapine. Ziprasidone is the second-generation drug causing the least weight gain. Risperidone, lurasidone, brexpiprazole, paliperidone, and aripiprazole usually produce small increases in weight and lipids. Asenapine and quetiapine have an intermediate effect. Clozapine and olanzapine frequently result in large increases in weight and lipids. Thus, these drugs should be considered as second-line drugs unless there is a specific indication. That is the case with clozapine, which at high doses (300\u2013900 mg/d) is effective in the majority of patients with schizophrenia refractory to other drugs, provided that treatment is continued for up to 6 months. Case reports and several clinical trials suggest that high-dose olanzapine, ie, doses of 30\u201345 mg/d, may also be"
        },
        {
            "id": "Neurology_Adams_12316",
            "title": "Neurology_Adams",
            "content": "In recent years a trend of early intervention with a first psychotic episode has gained favor. This includes a more thorough medical evaluation than had been typically conducted in the past and a team approach to reorienting the patient by providing straightforward cognitive behavioral or psychotherapy and family counseling. In some systems, this has seemingly reduced the incidence of relapse. The modern era of treatment of schizophrenia began in 1952, with the incidental demonstration by the French surgeon Henri Laborit of the antipsychosis properties of chlorpromazine. Subsequently, a large number of other phenothiazines have been used to treat chronic and acute psychosis. Treatment consists essentially of the administration of one of several similar antipsychotic medications. The various classes of antipsychotic drugs, their mode of action, and neurologic (\u201cneuroleptic\u201d) side effects are discussed in Chap. 41."
        },
        {
            "id": "Pharmacology_Katzung_2439",
            "title": "Pharmacology_Katzung",
            "content": "Roger J. Porter, MD, & Michael A. Rogawski, MD, PhD was unchanged, and levetiracetam was gradually increased to 1000 mg bid. The patient had no significant adverse effects from this dosage. At age 21, she had a second tonic-clonic seizure while in college; further discussion with her room-mate at that time revealed a history of two recent episodes of 1\u20132 minutes of altered consciousness with lip smacking (focal impaired awareness seizure, formerly complex partial seizure). A repeat EEG showed occasional right temporal spikes. What is one possible strategy for controlling her present symptoms? A 23-year-old woman presents to the office for consultation regarding her antiseizure medications. Seven years ago, this otherwise healthy young woman had a tonic-clonic seizure at home. She was rushed to the emergency department, at which time she was alert but complained of headache. A consulting neurologist placed her on levetiracetam, 500 mg bid. Four days later, electroencephalography (EEG)"
        },
        {
            "id": "Neurology_Adams_12319",
            "title": "Neurology_Adams",
            "content": "Clozapine, olanzapine, risperidone, quetiapine, and others listed in Table 49-2 are the more recently introduced atypical drugs with incompletely defined pharmacologic properties but with narrower affinities for certain receptors. In addition to their reduced motor side effects, they produce clinical improvement in about half of patients who have proved to be unresponsive to other antipsychotic medications. These drugs bind to and inhibit serotonin receptors and, to some extent, dopamine receptors (Meltzer and Nash), but have a much lower affinity for striatal dopamine receptors, thus providing a major advantage\u2014the absence of immediate or tardive extrapyramidal side effects. This has led most psychiatrists to use one of the newer drugs, rather than the phenothiazines, as a first choice. The addition of a second drug, specifically combining clozapine with risperidone, was not found to be useful in the trial conducted by Honer and colleagues. Moreover, in another one of the"
        },
        {
            "id": "InternalMed_Harrison_31767",
            "title": "InternalMed_Harrison",
            "content": "The risk of type 2 diabetes mellitus appears to be increased in schizophrenia, and second-generation agents as a group produce greater adverse effects on glucose regulation, independent of effects on obesity, than traditional agents. Clozapine, olanzapine, and quetiapine seem more likely to cause hyperglycemia, weight gain, and hypertriglyceridemia than other atypical antipsychotic drugs. Close monitoring of plasma glucose and lipid levels are indicated with the use of these agents."
        },
        {
            "id": "First_Aid_Step2_1230",
            "title": "First_Aid_Step2",
            "content": "Involuntary psychiatric hospitalization can be undertaken for which three reasons? True or false: Withdrawing a nonbeneficial treatment is ethically similar to withholding a nonindicated one. When can a physician refuse to continue treating a patient on the grounds of futility? An eight-year-old child is in a serious accident. She requires emergent transfusion, but her parents are not present. Conditions in which confidentiality must be overridden. Involuntary commitment or isolation for medical treatment may be undertaken for what reason? A 10-year-old child presents in status epilepticus, but her parents refuse treatment on religious grounds. A son asks that his mother not be told about her recently discovered cancer. False. Patients may change their minds at any time. Exceptions to the requirement of informed consent include emergency situations and patients without decision-making capacity."
        },
        {
            "id": "Pharmacology_Katzung_138",
            "title": "Pharmacology_Katzung",
            "content": "Mark von Zastrow, MD, PhD* A 51-year-old man presents to the emergency department due to acute difficulty breathing. The patient is afebrile and normotensive but anxious, tachycardic, and markedly tachy-pneic. Auscultation of the chest reveals diffuse wheezes. The physician provisionally makes the diagnosis of bronchial asthma and administers epinephrine by intramuscular injec-tion, improving the patient\u2019s breathing over several minutes. A normal chest X-ray is subsequently obtained, and the medical history is remarkable only for mild hypertension that is being treated with propranolol. The physician instructs the patient to discontinue use of propranolol, and changes the patient\u2019s antihypertensive medication to verapamil. Why is the physician correct to discontinue propranolol? Why is verapamil a better choice for managing hypertension in this patient? What alternative treatment change might the physi-cian consider?"
        },
        {
            "id": "InternalMed_Harrison_30451",
            "title": "InternalMed_Harrison",
            "content": "ziprasidone, and aripiprazole) are thought to be associated with a lower risk of TD in comparison to traditional antipsychotics, although this remains to be established in controlled studies. Younger patients have a lower risk of developing neuroleptic-induced TD, whereas the elderly, females, and those with underlying organic cerebral dysfunction have been reported to be at greater risk. Chronic use is associated with increased risk, and specifically, the U.S. Food and Drug Administration has warned that use of metoclopramide for more than 12 weeks increases the risk of TD. Because TD can be permanent and resistant to treatment, antipsychotics should be used judiciously, atypical neuroleptics should be the preferred agent when possible, and the need for continued use should be regularly monitored."
        },
        {
            "id": "Neurology_Adams_9678",
            "title": "Neurology_Adams",
            "content": "The antipsychotic agents in the class of clozapine (which is less used than other agents in the class because of cases of aplastic anemia) have attracted great interest, because\u2014as already mentioned\u2014they are associated with relatively fewer extrapyramidal side effects. For this reason, they are particularly favored in controlling the confusion and psychosis of parkinsonian patients. The other new class of drugs, of which risperidone is the main example, also has fewer extrapyramidal side effects than the phenothiazines and a more rapid onset of action than the traditional antipsychotic medications. All of these newer medications produce the \u201cmetabolic syndrome\u201d of weight gain, adverse lipid changes, and glucose intolerance. Pimozide may be useful in the treatment of haloperidol-refractory cases of Gilles de la Tourette syndrome (see Chap. 4); its main danger is its tendency to produce cardiac arrhythmias."
        },
        {
            "id": "Pharmacology_Katzung_3157",
            "title": "Pharmacology_Katzung",
            "content": "refractory to other drugs, provided that treatment is continued for up to 6 months. Case reports and several clinical trials suggest that high-dose olanzapine, ie, doses of 30\u201345 mg/d, may also be efficacious in refractory schizophrenia when given over a 6-month period. Clozapine is the only second-generation antipsychotic drug approved to reduce the risk of suicide in patients with history of schizophrenia. Patients with schizophrenia who have made life-threatening suicide attempts should be seriously evaluated for switching to clozapine."
        },
        {
            "id": "InternalMed_Harrison_31759",
            "title": "InternalMed_Harrison",
            "content": "Conventional neuroleptics differ in their potency and side effect profile. Older agents, such as chlorpromazine and thioridazine, are more sedating and anticholinergic and more likely to cause orthostatic hypotension, whereas higher potency antipsychotics, such as haloperidol, perphenazine, and thiothixene, are more likely to induce extrapyramidal side effects. The model \u201catypical\u201d antipsy chotic agent is clozapine, a dibenzodiazepine that has a greater potency in blocking the 5-HT2 than the D2 receptor and a much higher affinity for the D4 than the D2 receptor. Its principal disadvantage is a risk of blood dyscrasias. Paliperidone is a recently approved agent that is a metabolite of risperidone and shares many of its properties. Unlike other antipsychotics, clozapine does not cause a rise in prolactin level. Approximately 30% of patients who do not benefit from conventional antipsychotic agents will have a better response to this drug, which also has a demonstrated superiority to"
        },
        {
            "id": "InternalMed_Harrison_31756",
            "title": "InternalMed_Harrison",
            "content": "Schizophrenia is present in 0.85% of individuals worldwide, with a lifetime prevalence of ~1\u20131.5%. An estimated 300,000 episodes of acute schizophrenia occur annually in the United States, resulting in direct and indirect costs of $62.7 billion. The diagnosis is principally one of exclusion, requiring the absence of significant associated mood symptoms, any relevant medical condition, and substance abuse. Drug reactions that cause hallucinations, paranoia, confusion, or bizarre behavior may be dose-related or idiosyncratic; parkinsonian medications, clonidine, quinacrine, and procaine derivatives are the most common prescription medications associated with these symptoms. Drug causes should be ruled out in any case of newly emergent psychosis. The general neurologic examination in patients with schizophrenia is usually normal, but motor rigidity, tremor, and dyskinesias are noted in one-quarter of untreated patients."
        },
        {
            "id": "Pharmacology_Katzung_5601",
            "title": "Pharmacology_Katzung",
            "content": "A 65-year-old man undergoes cystoscopy because of the presence of microscopic hematuria in order to rule out urologic malignancy. The patient has mild dysuria and pyuria and empirically receives oral therapy with cip-rofloxacin for presumed urinary tract infection prior to the procedure and tolerates the procedure well. Approxi-mately 48 hours after the procedure, the patient presents to the emergency department with confusion, dysuria and chills. Physical exam reveals a blood pressure of 90/50, pulse of 120, temperature of 38.5\u00b0 C and respira-tory rate of 24. The patient is disoriented but the physical exam is otherwise unremarkable. Laboratory test shows WBC 24,000/mm3 and elevated serum lactate; urinalysis shows 300 WBC per high power field and 4+ bacteria. What possible organisms are likely to be responsible for the patient\u2019s symptoms? At this point, what antibiotic(s) would you choose for initial therapy of this potentially life-threatening infection?"
        },
        {
            "id": "Biochemistry_Lippincott_1323",
            "title": "Biochemistry_Lippinco",
            "content": "For Questions 27.7 and 27.8, use the following case. A sedentary 50-year-old man weighing 176 lb (80 kg) requests a physical. He denies any health problems. Routine blood analysis is unremarkable except for plasma total cholesterol of 295 mg/dl. (Reference value is <200 mg.) The man refuses drug therapy for his hypercholesterolemia. Analysis of a 1-day dietary recall showed the following: 7.4. Decreasing which one of the following dietary components would have the greatest effect in lowering the patient\u2019s plasma cholesterol? A. Carbohydrates B. Cholesterol C. Fiber D. Monounsaturated fat E. Polyunsaturated fat F. Saturated fat"
        },
        {
            "id": "First_Aid_Step1_637",
            "title": "First_Aid_Step1",
            "content": "2. Hallucinations, often auditory 3. 4. 5. Requires \u2265 1 month of active symptoms over the past 6 months; onset \u2265 6 months prior to diagnosis. Associated with altered dopaminergic activity, \u008f serotonergic activity, and \u0090 dendritic branching. Ventriculomegaly on brain imaging. Lifetime prevalence\u20141.5% (males > females). Presents earlier in men (late teens to early 20s) than in women (late 20s to early 30s). \u008f suicide risk. Heavy cannabis use in adolescence is associated with \u008f incidence and worsened course of psychotic, mood, and anxiety disorders. Treatment: atypical antipsychotics (eg, risperidone) are first line. Negative symptoms often persist after treatment, despite resolution of positive symptoms. Brief psychotic disorder\u2014\u2265 1 positive symptom(s) lasting < 1 month, usually stress-related. Schizophreniform disorder\u2014\u2265 2 symptoms lasting 1\u20136 months."
        },
        {
            "id": "InternalMed_Harrison_31712",
            "title": "InternalMed_Harrison",
            "content": "Regardless of the treatment undertaken, the response should be evaluated after ~2 months. Three-quarters of patients show improvement by this time, but if remission is inadequate, the patient should be questioned about compliance, and an increase in medication dose should be considered if side effects are not troublesome. If this approach is unsuccessful, referral to a mental health specialist is advised. Strategies for treatment then include selection of an alternative drug, combinations of antidepressants, and/or adjunctive treatment with other classes of drugs, including lithium, thyroid hormone, atypical antipsychotic agents, and dopamine agonists. A large randomized trial (STAR-D) was unable to show preferential efficacy, but the addition of certain atypical antipsychotic drugs (quetiapine extended-release; aripiprazole) has received FDA approval, as has usage of a combined medication, olanzapine and fluoxetine (Symbyax). Patients whose response to an SSRI wanes over time may"
        },
        {
            "id": "InternalMed_Harrison_30450",
            "title": "InternalMed_Harrison",
            "content": "These disorders develop months to years after initiation of neuroleptic treatment. Tardive dyskinesia (TD) is most common and typically presents with choreiform movements involving the mouth, lips, and tongue. In severe cases, the trunk, limbs, and respiratory muscles may also be affected. In approximately one-third of patients, TD remits within 3 months of stopping the drug, and most patients gradually improve over the course of several years. Abnormal movements may also develop or worsen after stopping the offending agent. The movements are often mild and more upsetting to the family than to the patient, but they can be severe and disabling, particularly in the context of an underlying psychiatric disorder. Atypical antipsychotics (e.g., clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole) are thought to be associated with a lower risk of TD in comparison to traditional antipsychotics, although this remains to be established in controlled studies. Younger"
        },
        {
            "id": "First_Aid_Step2_1261",
            "title": "First_Aid_Step2",
            "content": "A 13-year-old boy has a history of theft, vandalism, and violence toward family pets. A five-month-old girl has \u2193 head growth, truncal dyscoordination, and \u2193 social interaction. A patient hasn\u2019t slept for days, lost $20,000 gambling, is agitated, and has pressured speech. Diagnosis? Treatment? After a minor fender bender, a man wears a neck brace and requests permanent disability. A nurse presents with severe hypoglycemia; blood analysis reveals no elevation in C-peptide. A patient continues to use cocaine after being in jail, losing his job, and not paying child support. A violent patient has vertical and horizontal nystagmus. A woman who was abused as a child frequently feels outside of or detached from her body. A man has repeated, intense urges to rub his body against unsuspecting passengers on a bus. A schizophrenic patient takes haloperidol for one year and develops uncontrollable tongue movements. Diagnosis? Treatment?"
        },
        {
            "id": "Pharmacology_Katzung_5857",
            "title": "Pharmacology_Katzung",
            "content": "Edward Chu, MD are the possible benefits of adjuvant chemotherapy? The patient receives a combination of 5-fluorouracil (5-FU), leucovorin, and oxaliplatin (FOLFOX) as adjuvant therapy. One week after receiving the first cycle of therapy, he experiences significant toxicity in the form of myelosup-pression, diarrhea, and altered mental status. What is the most likely explanation for this increased toxicity? Is there any role for genetic testing to determine the etiology of the increased toxicity? A 55-year-old man presents with increasing fatigue, 15-pound weight loss, and a microcytic anemia. Colonoscopy identifies a mass in the ascending colon, and biopsy specimens reveal well-differentiated colorectal cancer (CRC). He undergoes surgical resection and is found to have high-risk stage III CRC with five positive lymph nodes. After surgery, he feels entirely well with no symptoms. Of note, he has no other illnesses. What is this patient\u2019s overall prognosis? Based on his prognosis, what"
        }
    ],
    "scores": [
        0.02784816590694074,
        0.026894178779580086,
        0.02626593545575802,
        0.02500800793707037,
        0.024732620320855617,
        0.024712052276076018,
        0.023750251905591713,
        0.023741986267592274,
        0.023584328129782676,
        0.02354366019737829,
        0.023072562358276642,
        0.02274185174019361,
        0.021972296772111988,
        0.02155441030560954,
        0.0207275325099069,
        0.01873249299719888,
        0.018723241705874343,
        0.01835016835016835,
        0.018305709705154497,
        0.017862838915470493,
        0.017507645259938837,
        0.017504683973558716,
        0.017460675848573793,
        0.01720573032048442,
        0.017073525138041265,
        0.01702405099971023,
        0.017009009009009007,
        0.016388047913650124,
        0.01598746081504702,
        0.01589323627540188,
        0.015756302521008403,
        0.015628686010851614
    ]
}